Hospital Intensive Monitoring of Adverse Drug Reactions of Qingkailing Injection In The Next Two Years

China Academy of Chinese Medical Sciences

Status: Completed

Conditions: Adverse Drug Events; Adverse Drug Reactions

Treatments: Drug: Qingkailing Injection

Study type: Observational

Funder types: Other

Identifiers

NCT01764204

Qingkailing-V5.0

Details and patient eligibility

About

To highlight the incidence of adverse reactions of Qingkailing Injection.

Enrollment: 30,840 patients

Sex: All

Ages: 1 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• all the patients treated by Qingkailing Injection in the certain centers(hospitals) in the next 2 years.
• in accordance with ethics requirements.

Exclusion criteria

• none.

Trial design

30,840 participants in 1 patient group

Qingkailing Injection

Treatment:

Drug: Qingkailing Injection